Y Mohri1, H Tonouchi, M Kobayashi, K Nakai, M Kusunoki. 1. Department of Gastrointestinal Surgery and Paediatric Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan. ya-mohri@clin.medic.mie-u.ac.jp
Abstract
BACKGROUND: The optimum duration of antimicrobial prophylaxis in elective gastric cancer surgery is still open to question. This multicentre randomized clinical trial compared a single-dose with a multiple-dose regimen of antimicrobial prophylaxis for prevention of surgical-site infection. METHODS:Between May 2001 and December 2004, 501 patients undergoing elective surgery for gastric cancer in ten centres were allocated randomly to single- or multiple-dose antimicrobial prophylaxis. The primary outcome measure was the incidence of surgical-site infection, analysed by intention to treat. RESULTS: Some 243 patients who received a single dose and 243 who received multiple doses of antibiotics were included in the final analysis. The surgical-site infection rate was 9.5 per cent (23 of 243) and 8.6 per cent (21 of 243) respectively (difference 0.9 (95 per cent confidence interval - 4.3 to 5.9) per cent). Antimicrobial prophylaxis had no major adverse effects. CONCLUSION: The incidence of surgical-site infection in elective gastric cancer surgery was similar with both antibiotic prophylaxis regimens. (c) 2007 British Journal of Surgery Society Ltd.
RCT Entities:
BACKGROUND: The optimum duration of antimicrobial prophylaxis in elective gastric cancer surgery is still open to question. This multicentre randomized clinical trial compared a single-dose with a multiple-dose regimen of antimicrobial prophylaxis for prevention of surgical-site infection. METHODS: Between May 2001 and December 2004, 501 patients undergoing elective surgery for gastric cancer in ten centres were allocated randomly to single- or multiple-dose antimicrobial prophylaxis. The primary outcome measure was the incidence of surgical-site infection, analysed by intention to treat. RESULTS: Some 243 patients who received a single dose and 243 who received multiple doses of antibiotics were included in the final analysis. The surgical-site infection rate was 9.5 per cent (23 of 243) and 8.6 per cent (21 of 243) respectively (difference 0.9 (95 per cent confidence interval - 4.3 to 5.9) per cent). Antimicrobial prophylaxis had no major adverse effects. CONCLUSION: The incidence of surgical-site infection in elective gastric cancer surgery was similar with both antibiotic prophylaxis regimens. (c) 2007 British Journal of Surgery Society Ltd.
Authors: Mehrdad Nikfarjam; Laurence Weinberg; Michael A Fink; Vijayaragavan Muralidharan; Graham Starkey; Robert Jones; Kevin Staveley-O'Carroll; Christopher Christophi Journal: World J Surg Date: 2014-02 Impact factor: 3.352
Authors: David H Craig; Cheri R Owen; William C Conway; Mary F Walsh; Christina Downey; Marc D Basson Journal: J Clin Invest Date: 2008-09 Impact factor: 14.808
Authors: Gary Duclos; Bruno Pastene; Fanny Depeyre; Zoé Meresse; Nadim Cassir; Ignacio Martin-Loeches; Sharon Einav; Laurent Zieleskiewicz; Marc Leone Journal: Ann Transl Med Date: 2018-10
Authors: Oh Jeong; Mi Ran Jung; Seong Yeob Ryu; Young-Kyu Park; Min Chan Kim; Ki Han Kim; Seung Wan Ryu; In Gyu Kwon; Young Gil Son Journal: Gastroenterol Res Pract Date: 2017-06-05 Impact factor: 2.260